Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Orth

Showing results (21-30 of 141) with videos related to

Pageof 15
Sort By:
Aging Clinical and Experimental Research|July 9, 2025
Incentives and practice improve prospective memory performance in older adultsMarta Menéndez-Granda, Nadine Schmidt, Michael Orth, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 19, 2011
Rate of change in early Huntington's disease: a clinicometric analysisChristina Meyer, Bernhard Landwehrmeyer, Carsten Schwenke, et al.
Experimental Neurology|November 28, 2016
Mitochondrial cristae remodelling is associated with disrupted OPA1 oligomerisation in the Huntington's disease R6/2 fragment modelTanja Hering, Kerstin Kojer, Nathalie Birth, et al.
Movement Disorders Clinical Practice|October 27, 2018
Comparison of Huntington's Disease in Europe and North AmericaMichael Orth, Juliana Bronzova, Christine Tritsch, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 22, 2019
Identification of symbol digit modality test score extremes in Huntington's diseaseUlrike Braisch, Rainer Muche, Dietrich Rothenbacher, et al.
Endocrinology|May 21, 2005
Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic miceSergiu Botolin, Marie-Claude Faugere, Hartmut Malluche, et al.
Plos One|May 26, 2017
The MTH1 inhibitor TH588 demonstrates anti-tumoral effects alone and in combination with everolimus, 5-FU and gamma-irradiation in neuroendocrine tumor cellsElke Tatjana Aristizabal Prada, Michael Orth, Svenja Nölting, et al.
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences|February 11, 2025
Factors Explaining Age-Related Prospective Memory Performance Differences: A Meta-analysisMarta Menéndez-Granda, Nadine Schmidt, Gianvito Laera, et al.
Journal of Huntington'S Disease|March 1, 2019
Huntingtin Aggregates and Mitochondrial Pathology in Skeletal Muscle but not Heart of Late-Stage R6/2 MiceKerstin Kojer, Tanja Hering, Chantal Bazenet, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 3, 2008
Fragile X syndrome associated with tic disordersSusanne A Schneider, Mary M Robertson, Renata Rizzo, et al.
Pageof 15

Showing results (21-30 of 141) with videos related to

Sort By:
Pageof 15
Aging Clinical and Experimental Research|July 9, 2025
Incentives and practice improve prospective memory performance in older adultsMarta Menéndez-Granda, Nadine Schmidt, Michael Orth, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 19, 2011
Rate of change in early Huntington's disease: a clinicometric analysisChristina Meyer, Bernhard Landwehrmeyer, Carsten Schwenke, et al.
Experimental Neurology|November 28, 2016
Mitochondrial cristae remodelling is associated with disrupted OPA1 oligomerisation in the Huntington's disease R6/2 fragment modelTanja Hering, Kerstin Kojer, Nathalie Birth, et al.
Movement Disorders Clinical Practice|October 27, 2018
Comparison of Huntington's Disease in Europe and North AmericaMichael Orth, Juliana Bronzova, Christine Tritsch, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 22, 2019
Identification of symbol digit modality test score extremes in Huntington's diseaseUlrike Braisch, Rainer Muche, Dietrich Rothenbacher, et al.
Endocrinology|May 21, 2005
Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic miceSergiu Botolin, Marie-Claude Faugere, Hartmut Malluche, et al.
Plos One|May 26, 2017
The MTH1 inhibitor TH588 demonstrates anti-tumoral effects alone and in combination with everolimus, 5-FU and gamma-irradiation in neuroendocrine tumor cellsElke Tatjana Aristizabal Prada, Michael Orth, Svenja Nölting, et al.
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences|February 11, 2025
Factors Explaining Age-Related Prospective Memory Performance Differences: A Meta-analysisMarta Menéndez-Granda, Nadine Schmidt, Gianvito Laera, et al.
Journal of Huntington'S Disease|March 1, 2019
Huntingtin Aggregates and Mitochondrial Pathology in Skeletal Muscle but not Heart of Late-Stage R6/2 MiceKerstin Kojer, Tanja Hering, Chantal Bazenet, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 3, 2008
Fragile X syndrome associated with tic disordersSusanne A Schneider, Mary M Robertson, Renata Rizzo, et al.
Pageof 15